Background: Ocular complications are one of the well-recognized extra-articular complications of rheumatoid arthritis [RA]. The most common ocular complications of RA are Keratoconjunctivitis sicca, episcleritis, scleritis, marginal thinning of the cornea with keratolysis, stromal corneal opacities with peripheral vascularization, and iridocyclitis. The ocular complications were found to be significantly higher in patients with long duration of RA. Aim of the work: This study was conducted to determine the common ocular complications that occur with RA and to determine the correlation of this complications with age, gender, duration, and activity of RA. Patients and methods: Tow hundred eyes of one hundred patients [males and females] with symptomatic evidence of RA were studied. All patients subjected to full clinical evaluation, laboratory assessment, plain X-ray hand and detailed ocular examination [visual acuity, slit lamp, fundus examination and Schirmer's test]. Results: Our research showed that 47.0% of the studied cases were aged from 41 to 60 years old, 93.0% of them were females, 57.0 % of them had RA more than 2 years [longstanding RA] and 40.0 % of them had ocular complications. The most common eye complications among the studied cases were dry eye, episcleritis, and scleritis [28.5 %, 4.0 %, and 3.0 % respectively]. Conclusion: RA patients have a higher risk of ocular complications. Eye examination should be included as a routin for RA patients to facilitate early diagnosis and management of ocular complications. This is an open access article under the Creative Commons license [CC BY] [https://creativecommons.org/licenses/by/2.0/] Please cite this article as: Alzokm SM, Ghali AA. Ocular complications in rheumatoid patients at Damietta government: Correlation with age, gender and disease activity. IJMA 2019; 1[2]: 144-151.
INTRODUCTION:
Rheumatoid arthritis [RA] is a chronic systemic autoimmune disease of unknown etiology that has articular and extra-articular manifestations, including ophthalmic involvement [1] . The clinical course of eye disease may be quite variable. Early diagnosis of eye disease in RA patient is very important since it permits the early management of potentially serious sight-threatening complications. The presence of the eye disease may also be an indicator of systemic disease activity [2] [3] [4] . However, ocular involvement particularly in severe dry eye, may exist independently from severe articular disease and should be evaluated in all RA patients regardless of extra-ophthalmic manifestations [5] [6] .
PATIENTS AND METHODS

Patients:
This study included 200 eyes of 100 RA patients [males and females] who attended to the outpatient clinic of the departments of ophthalmology and rheumatology, AL-Azhar University Hospital, Damietta, Egypt. The patients were diagnosed according to ACR criteria 1987 [7] or ACR/EULAR 2010 criteria, which of these the patients fulfill.
All patients were recruited from Damietta, Al-Azhar University Hospital, from February 2018 and January 2019. The patients selected randomly. Randomization based on a single sequence of random assignments [simple Randomization]. The protocol of this study was approved by the local ethics and research committee of Al-Azhar Faculty of Medicine [New Damietta], and informed consent was signed by all patients before inclusion in this study. Frequency and percentage were used, chi-square and Fisher exact tests was used for testing the significance of observed differences between studied patients. The level of significance was adopted at p < 0.05. [1] . Eye complications were found in 46 % of our study population.
RESULTS
Demographic
Reddy et al. [9] found the incidence of eye complications in RA were 39% in100 patients. Also, Vignesh and Srinivasan [10] found the incidence of eye manifestations in RA were 39% of 196 patients. The incidence in our study slightly elevated from the previous studies, this may be due to the geographic difference.
The most common eye complications in our patients are dry eye [28.5%] and this agrees with Vignesh and Srinivasan [10] in their study found the incidence of dry eye was 28%. Also Punjabi et al. [11] reported that 27.3% of RA patients had dry eye in an Indian population, but Bettero et al. [12] , reported secondary Sjögren's syndrome in 12.1% of the population with RA and Reddy and Rao [13] in there study found the incidence of dry eye was 16.6 %.
Dry eye results from decreased secretion of tears from the lacrimal glands due to atrophic and cirrhotic changes. The combination of this disease with dryness of mouth is referred to as the sicca syndrome. When associated with RA or another connective tissue disorder, the resultant triad is known as Sjögren's syndrome [14] .
Keratitis and corneal ulceration may develop in such patients if the disease is not treated early. The diagnosis of secondary Sjögren's was made based on the American-European Consensus Criteria for Sjögren's syndrome which was based on the duration of symptoms, Schirmer's test, and positive vital dye staining of the eye surface. Tear film osmolality also correlates with dry eye activity.
Tong et al. [15] found that tear film osmolality correlated with the severity of dry eye score. So, more research is needed on the markers of the eye surface in RA. Tong et al at. [15] studied the immune markers that lead to dryness of the eye and correlated with a disease activity.
Villani et al. [16] found that immunesuppression modified the eye surface pathology in RA patients with secondary Sjögren's syndrome. Also, Villani et al. [17] found the corneal surface activity was more in patients with secondary Sjögren's.
The second eye complication in our patients was episcleritis[ 4.0 % ]and this agrees with Reddy et al. [9] , that in their study they found the incidence of episcleritis was 3.7 % in RA patients, and also agree with Vignesh and Srinivasan [10] that in their study they found the incidence of episcleritis was 3%. But, McGavin et al. [2] studied 4,210 RA patients and established the incidence of episcleritis was 0.I7%. Bhadoria et al. [18] reported episcleritis in 0.93% of the patients.
The episclera is a thin layer of tissue that lies between the conjunctiva and the sclera. Episcleritis is a common condition, characterized by painless eye redness, typically presenting as redness, irritation, and watering of the eye with preserved vision. Most cases of episcleritis respond well to topical therapy alone and do not threat the vision. Many cases of episcleritis require no treatment and typically resolve over a short time. The third eye complication in our patients was scleritis [3.0%] and this agrees with Vignesh and Srinivasan [10] that, found the incidence of scleritis was 2%. But Reddy et al. [9] found the incidence of scleritis was 0.9 % in RA patients and McGavin et al. [2] reported the incidence of scleritis was 0.67% in RA patients.
The scleritis can be isolated to the eye, but about half of the affected cases it occurs secondary to an auto immune disease, such as rheumatoid arthritis or Wegener's granulomatosis. Although uncommon, scleritis is often extremely painful condition and can lead to threatening of the vision.Scleritis is three types: the most common type is diffuse scleritis. The second type is nodular scleritis, and the third type is necrotizing scleritis and it the most severe type. Scleritis may be the early manifestation of autoimmune diseases. Corneal neovascularization is the in-growth of new blood vessels from the pericorneal plexus into avascular corneal tissue as a result of oxygen deprivation [19] .
Corneal transparency is dependent on maintaining avascularity of the cornea that required for optimal vision. If corneal transparency decreased the visual acuity will deteriorate. The Cornea is avascular in nature and the presence of vascularization, which can be deep or superficial, is always pathologically related [20] .
Corneal neovascularization [CNV] is a condition that threats the vision and caused by any cause of inflammation. Common causes of CNV are infection, chemical injury, autoimmune conditions, post-corneal transplantation, and traumatic conditions. Other causes are trachoma, corneal ulcers, rosacea keratitis, interstitial keratitis, sclerosing keratitis, chemical burns, and wearing contact lenses for long time [21] . CNV may be Superficial and are usually occurred with wearing of contact lens for long time and may be deep and caused by chronic inflammation and anterior eye segment diseases [22] .
CNV in our study represent [2.0 %] of RA patients but the previous researches did not detect this complication so we may be the first research detect this sight-threatening condition with RA. The majority of eye complications seen in our study were in longstanding RA [56.14%], with significant difference [0.001] which was comparable to Vignesh and Srinivasan [10] in which the duration of RA in the patients with vision-threatening conditions like sclerosing keratitis and PUK was 10.5 years. Bettero et al. [12] reported eye complications in the patients who had a long duration of RA.
Our study demonstrated that the eye complications of RA seen in patients with high [2] , Foster et al. [3] and Dana at al. [4] , demonstrated that the eye complications of RA seen in patients with a more severe form of the disease, and often exacerbated with increased activity of the disease.
Conclusion and recommendation: This study indicates that eye involvement is very common and the need for close follow-up. The rheumatologists should get an ocular examination as a routine for all RA patients at diagnosis and then at periodic intervals for early detection of any ocular involvement.
